These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

360 related articles for article (PubMed ID: 24447505)

  • 1. Context-dependent activation of Wnt signaling by tumor suppressor RUNX3 in gastric cancer cells.
    Ju X; Ishikawa TO; Naka K; Ito K; Ito Y; Oshima M
    Cancer Sci; 2014 Apr; 105(4):418-24. PubMed ID: 24447505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. p15RS attenuates Wnt/{beta}-catenin signaling by disrupting {beta}-catenin·TCF4 Interaction.
    Wu Y; Zhang Y; Zhang H; Yang X; Wang Y; Ren F; Liu H; Zhai Y; Jia B; Yu J; Chang Z
    J Biol Chem; 2010 Nov; 285(45):34621-31. PubMed ID: 20739273
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A dynamic exchange of TCF3 and TCF4 transcription factors controls MYC expression in colorectal cancer cells.
    Shah M; Rennoll SA; Raup-Konsavage WM; Yochum GS
    Cell Cycle; 2015; 14(3):323-32. PubMed ID: 25659031
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Human telomerase reverse transcriptase (hTERT) is a novel target of the Wnt/β-catenin pathway in human cancer.
    Zhang Y; Toh L; Lau P; Wang X
    J Biol Chem; 2012 Sep; 287(39):32494-511. PubMed ID: 22854964
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ITF2 prevents activation of the β-catenin-TCF4 complex in colon cancer cells and levels decrease with tumor progression.
    Shin HW; Choi H; So D; Kim YI; Cho K; Chung HJ; Lee KH; Chun YS; Cho CH; Kang GH; Kim WH; Park JW
    Gastroenterology; 2014 Aug; 147(2):430-442.e8. PubMed ID: 24846398
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CREPT/RPRD1B, a recently identified novel protein highly expressed in tumors, enhances the β-catenin·TCF4 transcriptional activity in response to Wnt signaling.
    Zhang Y; Liu C; Duan X; Ren F; Li S; Jin Z; Wang Y; Feng Y; Liu Z; Chang Z
    J Biol Chem; 2014 Aug; 289(33):22589-22599. PubMed ID: 24982424
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Down-regulation of Sox7 is associated with aberrant activation of Wnt/b-catenin signaling in endometrial cancer.
    Chan DW; Mak CS; Leung TH; Chan KK; Ngan HY
    Oncotarget; 2012 Dec; 3(12):1546-56. PubMed ID: 23295859
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The TCF4/β-catenin pathway and chromatin structure cooperate to regulate D-glucuronyl C5-epimerase expression in breast cancer.
    Mostovich LA; Prudnikova TY; Kondratov AG; Gubanova NV; Kharchenko OA; Kutsenko OS; Vavilov PV; Haraldson K; Kashuba VI; Ernberg I; Zabarovsky ER; Grigorieva EV
    Epigenetics; 2012 Aug; 7(8):930-9. PubMed ID: 22805760
    [TBL] [Abstract][Full Text] [Related]  

  • 9. p15RS/RPRD1A (p15INK4b-related sequence/regulation of nuclear pre-mRNA domain-containing protein 1A) interacts with HDAC2 in inhibition of the Wnt/β-catenin signaling pathway.
    Liu C; Zhang Y; Li J; Wang Y; Ren F; Zhou Y; Wu Y; Feng Y; Zhou Y; Su F; Jia B; Wang D; Chang Z
    J Biol Chem; 2015 Apr; 290(15):9701-13. PubMed ID: 25697359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. ZEB1 and TCF4 reciprocally modulate their transcriptional activities to regulate Wnt target gene expression.
    Sánchez-Tilló E; de Barrios O; Valls E; Darling DS; Castells A; Postigo A
    Oncogene; 2015 Nov; 34(46):5760-70. PubMed ID: 26387539
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Henryin, an ent-kaurane diterpenoid, inhibits Wnt signaling through interference with β-catenin/TCF4 interaction in colorectal cancer cells.
    Li X; Pu J; Jiang S; Su J; Kong L; Mao B; Sun H; Li Y
    PLoS One; 2013; 8(7):e68525. PubMed ID: 23844215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DEAD-box protein p68 is regulated by β-catenin/transcription factor 4 to maintain a positive feedback loop in control of breast cancer progression.
    Guturi KK; Sarkar M; Bhowmik A; Das N; Ghosh MK
    Breast Cancer Res; 2014 Dec; 16(6):496. PubMed ID: 25499975
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VDR/RXR and TCF4/β-catenin cistromes in colonic cells of colorectal tumor origin: impact on c-FOS and c-MYC gene expression.
    Meyer MB; Goetsch PD; Pike JW
    Mol Endocrinol; 2012 Jan; 26(1):37-51. PubMed ID: 22108803
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The Wnt/β-catenin and PI3K/Akt signaling pathways promote EMT in gastric cancer by epigenetic regulation via H3 lysine 27 acetylation.
    Song Y; Li ZX; Liu X; Wang R; Li LW; Zhang Q
    Tumour Biol; 2017 Jul; 39(7):1010428317712617. PubMed ID: 28671020
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oncogenic KRAS signalling promotes the Wnt/β-catenin pathway through LRP6 in colorectal cancer.
    Lemieux E; Cagnol S; Beaudry K; Carrier J; Rivard N
    Oncogene; 2015 Sep; 34(38):4914-27. PubMed ID: 25500543
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of the Wnt/β-catenin pathway represses the transcription of the β-amyloid precursor protein cleaving enzyme (BACE1) via binding of T-cell factor-4 to BACE1 promoter.
    Parr C; Mirzaei N; Christian M; Sastre M
    FASEB J; 2015 Feb; 29(2):623-35. PubMed ID: 25384422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SOX9 regulates low density lipoprotein receptor-related protein 6 (LRP6) and T-cell factor 4 (TCF4) expression and Wnt/β-catenin activation in breast cancer.
    Wang H; He L; Ma F; Regan MM; Balk SP; Richardson AL; Yuan X
    J Biol Chem; 2013 Mar; 288(9):6478-87. PubMed ID: 23306204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bach1 Represses Wnt/β-Catenin Signaling and Angiogenesis.
    Jiang L; Yin M; Wei X; Liu J; Wang X; Niu C; Kang X; Xu J; Zhou Z; Sun S; Wang X; Zheng X; Duan S; Yao K; Qian R; Sun N; Chen A; Wang R; Zhang J; Chen S; Meng D
    Circ Res; 2015 Jul; 117(4):364-375. PubMed ID: 26123998
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MENA is a transcriptional target of the Wnt/beta-catenin pathway.
    Najafov A; Seker T; Even I; Hoxhaj G; Selvi O; Ozel DE; Koman A; Birgül-İyison N
    PLoS One; 2012; 7(5):e37013. PubMed ID: 22615875
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RUNX3 attenuates beta-catenin/T cell factors in intestinal tumorigenesis.
    Ito K; Lim AC; Salto-Tellez M; Motoda L; Osato M; Chuang LS; Lee CW; Voon DC; Koo JK; Wang H; Fukamachi H; Ito Y
    Cancer Cell; 2008 Sep; 14(3):226-37. PubMed ID: 18772112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.